subject area of
- A Computationally Designed Hemagglutinin Stem-Binding Protein Provides In Vivo Protection from Influenza Independent of a Host Immune Response Academic Article
- A Single Immunization with Nucleoside-Modified mRNA Vaccines Elicits Strong Cellular and Humoral Immune Responses against SARS-CoV-2 in Mice Academic Article
- A blueprint for HIV vaccine discovery Academic Article
- A broadly neutralizing human monoclonal antibody exhibits in vivo efficacy against both human metapneumovirus and respiratory syncytial virus Academic Article
- A chimeric hiv-1 envelope glycoprotein trimer with an embedded granulocyte-macrophage colony-stimulating factor (gm-csf) domain induces enhanced antibody and t cell responses Academic Article
- A common solution to group 2 influenza virus neutralization Academic Article
- A gp41 MPER-specific llama VHH requires a hydrophobic CDR3 for neutralization but not for antigen recognition Academic Article
- A highly conserved cryptic epitope in the receptor binding domains of SARS-CoV-2 and SARS-CoV Academic Article
- A highly conserved neutralizing epitope on group 2 influenza a viruses Academic Article
- A human antibody to the CD4 binding site of gp120 capable of highly potent but sporadic cross clade neutralization of primary HIV-1 Academic Article
- A human inferred germline antibody binds to an immunodominant epitope and neutralizes Zika virus Academic Article
- A lentiviral vector allowing physiologically regulated membrane-anchored and secreted antibody expression depending on B-cell maturation status Academic Article
- A limited number of antibody specificities mediate broad and potent serum neutralization in selected HIV-1 infected individuals Academic Article
- A next-generation cleaved, soluble HIV-1 Env Trimer, BG505 SOSIP.664 gp140, expresses multiple epitopes for broadly neutralizing but not non-neutralizing antibodies Academic Article
- A novel strategy for efficient production of anti-V3 human scFvs against HIV-1 clade C Academic Article
- A panel of igg1 b12 variants with selectively diminished or enhanced affinity for fc gamma receptors to define the role of effector functions in protection against hiv Academic Article
- A perspective on the structural and functional constraints for immune evasion: insights from influenza virus Academic Article
- A potent and broad neutralizing antibody recognizes and penetrates the HIV glycan shield Academic Article
- A recurring motif for antibody recognition of the receptor-binding site of influenza hemagglutinin Academic Article
- A shared structural solution for neutralizing ebolaviruses Academic Article
- A short segment of the hiv-1 gp120 v1/v2 region is a major determinant of resistance to v1/v2 neutralizing antibodies Academic Article
- A single human papillomavirus vaccine dose improves B cell memory in previously infected subjects Academic Article
- A stable trimeric influenza hemagglutinin stem as a broadly protective immunogen Academic Article
- A two-antibody pan-ebolavirus cocktail confers broad therapeutic protection in ferrets and nonhuman primates Academic Article
- A unique and conserved neutralization epitope in H5N1 influenza viruses identified by an antibody against the A/Goose/Guangdong/1/96 hemagglutinin Academic Article
- A virus-like particle that elicits cross-reactive antibodies to the conserved stem of influenza virus hemagglutinin Academic Article
- AAV-expressed eCD4-Ig provides durable protection from multiple SHIV challenges Academic Article
- Advances in structure-based vaccine design Academic Article
- Affinity maturation of a potent family of HIV antibodies is primarily focused on accommodating or avoiding glycans Academic Article
- An Alternative Binding Mode of IGHV3-53 Antibodies to the SARS-CoV-2 Receptor Binding Domain Academic Article
- An engineered mutant of hiv-1 gp120 formulated with adjuvant quil a promotes elicitation of antibody responses overlapping the cd4-binding site Academic Article
- Analysis of a clonal lineage of HIV-1 envelope V2/V3 conformational epitope-specific broadly neutralizing antibodies and their inferred unmutated common ancestors Academic Article
- Anti-HIV B Cell lines as candidate vaccine biosensors Academic Article
- Antibodies that cross-neutralize the tier-2 pseudoviruses are produced in antiretroviral-naive HIV-1-infected children from northern India Academic Article
- Antibodies to a conformational epitope on gp41 neutralize HIV-1 by destabilizing the Env spike Academic Article
- Antibody 2g12 recognizes di-mannose equivalently in domain- and nondomain-exchanged forms but only binds the hiv-1 glycan shield if domain exchanged Academic Article
- Antibody 8ANC195 reveals a site of broad vulnerability on the HIV-1 envelope spike Academic Article
- Antibody SPC-54 provides acute in vivo blockage of the murine protein C system Academic Article
- Antibody conjugation approach enhances breadth and potency of neutralization of anti-HIV-1 antibodies and CD4-IgG Academic Article
- Antibody potency relates to the ability to recognize the closed, pre-fusion form of HIV Env Academic Article
- Antibody responses to envelope glycoproteins in HIV-1 infection Academic Article
- Antibody to gp41 MPER alters functional properties of HIV-1 Env without complete neutralization Academic Article
- Antibody-mediated neutralization of ebola virus can occur by two distinct mechanisms Academic Article
- Approaching rational epitope vaccine design for hepatitis C virus with meta-server and multivalent scaffolding Academic Article
- Aromatic residues at the edge of the antibody combining site facilitate viral glycoprotein recognition through membrane interactions Academic Article
- Asymmetric recognition of the HIV-1 trimer by broadly neutralizing antibody PG9 Academic Article
- B cell liaison confounds HIV-1 evolution Academic Article
- B cells expressing authentic naive human VRC01-class BCRs can be recruited to germinal centers and affinity mature in multiple independent mouse models Academic Article
- B cells from knock-in mice expressing broadly neutralizing HIV antibody b12 carry an innocuous B cell receptor responsive to HIV vaccine candidates Academic Article
- Biochemically defined hiv-1 envelope glycoprotein variant immunogens display differential binding and neutralizing specificities to the cd4-binding site Academic Article
- Blys-mediated modulation of naive b cell subsets impacts hiv env-induced antibody responses Academic Article
- Bone marrow plasma cells are a primary source of serum HIV-1-specific antibodies in chronically infected individuals Academic Article
- Breadth of human immunodeficiency virus-specific neutralizing activity in sera: Clustering analysis and association with clinical variables Academic Article
- Breadth of neutralization and synergy of clinically relevant human monoclonal antibodies against HCV genotypes 1a, 1b, 2a, 2b, 2c, and 3a Academic Article
- Broad and potent HIV-1 neutralization by a human antibody that binds the gp41-gp120 interface Academic Article
- Broad and potent neutralization of hiv-1 by a gp41-specific human antibody Academic Article
- Broad neutralization coverage of HIV by multiple highly potent antibodies Academic Article
- Broadly neutralizing HIV antibodies define a glycan-dependent epitope on the prefusion conformation of gp41 on cleaved envelope trimers Academic Article
- Broadly neutralizing antibodies abrogate established hepatitis C virus infection Academic Article
- Broadly neutralizing antibodies against influenza virus and prospects for universal therapies Academic Article
- Broadly neutralizing antibodies against influenza viruses Academic Article
- Broadly neutralizing antibodies present new prospects to counter highly antigenically diverse viruses Academic Article
- Broadly neutralizing antibody PGT121 allosterically modulates CD4 binding via recognition of the HIV-1 gp120 V3 base and multiple surrounding glycans Academic Article
- Broadly neutralizing antibody responses in a large longitudinal Sub-Saharan HIV primary infection cohort Academic Article
- Broadly neutralizing monoclonal antibodies 2f5 and 4e10 directed against the human immunodeficiency virus type 1 gp41 membrane-proximal external region protect against mucosal challenge by simian-human immunodeficiency virus shivba-l Academic Article
- Capitalizing on knowledge of hepatitis C virus neutralizing epitopes for rational vaccine design Academic Article
- Challenges for structure-based HIV vaccine design Academic Article
- Characterization of a broadly neutralizing monoclonal antibody that targets the fusion domain of group 2 influenza A virus hemagglutinin Academic Article
- Characterization of virus-like particles in GARDASIL by cryo transmission electron microscopy Academic Article
- Chemical cross-linking stabilizes native-like HIV-1 envelope glycoprotein trimer antigens Academic Article
- Chimeric hemagglutinin vaccine elicits broadly protective CD4 and CD8 T cell responses against multiple influenza strains and subtypes Academic Article
- Co-evolution of a broadly neutralizing HIV-1 antibody and founder virus Academic Article
- Complete epitopes for vaccine design derived from a crystal structure of the broadly neutralizing antibodies PGT128 and 8ANC195 in complex with an HIV-1 Env trimer Academic Article
- Comprehensive antigenic map of a cleaved soluble HIV-1 envelope trimer Academic Article
- Computation-guided backbone grafting of a discontinuous motif onto a protein scaffold Academic Article
- Computational design of protein antigens that interact with the CDR H3 loop of HIV broadly neutralizing antibody 2F5 Academic Article
- Computational prediction of broadly neutralizing HIV-1 antibody epitopes from neutralization activity data Academic Article
- Conformational dynamics of single HIV-1 envelope trimers on the surface of native virions Academic Article
- Context matters: The importance of dimerization-induced conformation of the LukGH leukocidin of Staphylococcus aureus for the generation of neutralizing antibodies Academic Article
- Contribution of an unusual CDR2 element of a single domain antibody in ricin toxin binding affinity and neutralizing activity Academic Article
- Cooperativity enables non-neutralizing antibodies to neutralize Ebolavirus Academic Article
- Cross-neutralization of influenza a viruses mediated by a single antibody loop Academic Article
- Cross-reactive Antibody Response between SARS-CoV-2 and SARS-CoV Infections
- Cross-reactive and potent neutralizing antibody responses in human survivors of natural Ebolavirus infection Academic Article
- Cryo-EM structure of a fully glycosylated soluble cleaved HIV-1 envelope trimer Academic Article
- Cryo-EM structure of a native, fully glycosylated, cleaved HIV-1 envelope trimer Academic Article
- Crystal structure of PG16 and chimeric dissection with somatically related PG9: structure-function analysis of two quaternary-specific antibodies that effectively neutralize HIV-1 Academic Article
- Crystal structure of a soluble cleaved HIV-1 envelope trimer Academic Article
- Crystal structure of human antibody 2909 reveals conserved features of quaternary structure-specific antibodies that potently neutralize HIV-1 Academic Article
- Crystal structure of the HIV neutralizing antibody 2G12 in complex with a bacterial oligosaccharide analog of mammalian oligomannose Academic Article
- Crystallographic identification of lipid as an integral component of the epitope of HIV broadly neutralizing antibody 4E10 Academic Article
- De novo identification of VRC01 class HIV-1-neutralizing antibodies by next-generation sequencing of B-cell transcripts Academic Article
- Development of a human antibody cocktail that deploys multiple functions to confer pan-ebolavirus protection Academic Article
- Developmental pathway for potent V1V2-directed HIV-neutralizing antibodies Academic Article
- Different genetic barriers for resistance to HA stem antibodies in influenza H3 and H1 viruses Academic Article
- Differential binding of neutralizing and non-neutralizing antibodies to native-like soluble HIV-1 Env trimers, uncleaved Env proteins, and monomeric subunits Academic Article
- Direct antibody access to the HIV-1 membrane-proximal external region positively correlates with neutralization sensitivity Academic Article
- Disrupted adenovirus-based vaccines against small addictive molecules circumvent anti-adenovirus immunity Academic Article
- Diverse antibody genetic and recognition properties revealed following HIV-1 envelope glycoprotein immunization Academic Article
- Drift of the HIV-1 envelope glycoprotein gp120 toward increased neutralization resistance over the course of the epidemic: a comprehensive study using the most potent and broadly neutralizing monoclonal antibodies Academic Article
- Ebola virus glycoprotein needs an additional trigger, beyond proteolytic priming for membrane fusion Academic Article
- Effect of single-point mutations on the stability and immunogenicity of a recombinant ricin A chain subunit vaccine antigen Academic Article
- Engineering HIV envelope protein to activate germline B cell receptors of broadly neutralizing anti-CD4 binding site antibodies Academic Article
- Enhanced recognition and neutralization of HIV-1 by antibody-derived CCR5-mimetic peptide variants Academic Article
- Escape from neutralization by the respiratory syncytial virus-specific neutralizing monoclonal antibody palivizumab is driven by changes in on-rate of binding to the fusion protein Academic Article
- Fab mabs specific to ha of influenza virus with h5n1 neutralizing activity selected from immunized chicken phage library Academic Article
- Focused evolution of HIV-1 neutralizing antibodies revealed by structures and deep sequencing Academic Article
- Functional optimization of broadly neutralizing HIV-1 antibody 10E8 by promotion of membrane interactions Academic Article
- Functional stability of HIV-1 envelope trimer affects accessibility to broadly neutralizing antibodies at its apex Academic Article
- Fusion peptide of HIV-1 as a site of vulnerability to neutralizing antibody Academic Article
- Glycan clustering stabilizes the mannose patch of HIV-1 and preserves vulnerability to broadly neutralizing antibodies Academic Article
- Glycan masking of Plasmodium vivax Duffy Binding Protein for probing protein binding function and vaccine development Academic Article
- Glycoengineering HIV-1 Env creates 'supercharged' and 'hybrid' glycans to increase neutralizing antibody potency, breadth and saturation Academic Article
- H7N9 influenza virus neutralizing antibodies that possess few somatic mutations Academic Article
- HIV envelope glycoform heterogeneity and localized diversity govern the initiation and maturation of a V2 apex broadly neutralizing antibody lineage Academic Article
- HIV-1 broadly neutralizing antibody precursor B cells revealed by germline-targeting immunogene Academic Article
- HIV-1 envelope glycoprotein trimer immunogenicity elicited in the presence of human CD4 alters the neutralization profile Academic Article
- HIV-1 neutralizing antibodies induced by native-like envelope trimers Academic Article
- HIV-1 neutralizing antibodies induced by native-like envelope trimers Academic Article
- HIV-1 receptor binding site-directed antibodies using a VH1-2 gene segment orthologue are activated by Env trimer immunization Academic Article
- Hepatitis C virus E2 envelope glycoprotein core structure Academic Article
- Heterologous epitope-scaffold prime:Boosting immuno-focuses b cell responses to the hiv-1 gp41 2f5 neutralization determinant Academic Article
- Heterosubtypic antibodies to influenza A virus have limited activity against cell-bound virus but are not impaired by strain-specific serum antibodies Academic Article
- Heterosubtypic antibody recognition of the influenza virus hemagglutinin receptor binding site enhanced by avidity Academic Article
- High-resolution definition of vaccine-elicited b cell responses against the hiv primary receptor binding site Academic Article
- High-throughput protein engineering improves the antigenicity and stability of soluble HIV-1 envelope glycoprotein SOSIP trimers Academic Article
- High-throughput screening technologies for botulinum neurotoxins Academic Article
- Highly conserved protective epitopes on influenza B viruses Academic Article
- Highly efficient neutralization by plasma antibodies from human immunodeficiency virus type-1 infected individuals on antiretroviral drug therapy Academic Article
- Highly potent hiv-specific antibody neutralization in vitro translates into effective protection against mucosal shiv challenge in vivo Academic Article
- Hiv type 1 env precursor cleavage state affects recognition by both neutralizing and nonneutralizing gp41 antibodies Academic Article
- Hiv-1 neutralizing antibodies display dual recognition of the primary and coreceptor binding sites and preferential binding to fully cleaved envelope glycoproteins Academic Article
- Human antibodies that neutralize respiratory droplet transmissible H5N1 influenza viruses Academic Article
- Human broadly neutralizing antibodies to the envelope glycoprotein complex of hepatitis C virus Academic Article
- Human circulating PD-(+)1CXCR3(-)CXCR5(+) memory Tfh cells are highly functional and correlate with broadly neutralizing HIV antibody responses Academic Article
- Hyperglycosylated stable core immunogens designed to present the CD4 binding site are preferentially recognized by broadly neutralizing antibodies Academic Article
- IDEPI: rapid prediction of HIV-1 antibody epitopes and other phenotypic features from sequence data using a flexible machine learning platform Academic Article
- IL-7/anti-IL-7 mAb complexes augment cytokine potency in mice through association with IgG-Fc and by competition with IL-7R Academic Article
- Identification and characterization of a naturally occurring, efficiently cleaved, membrane-bound, clade A HIV-1 Env, suitable for immunogen design, with properties comparable to membrane-bound BG505 Academic Article
- Identification of CD4-binding site dependent plasma neutralizing antibodies in an HIV-1 Infected Indian individual Academic Article
- Identification of an HIV-1 clade A envelope that exhibits broad antigenicity and neutralization sensitivity and elicits antibodies targeting three distinct epitopes Academic Article
- Identification of common features in prototype broadly neutralizing antibodies to HIV envelope V2 apex to facilitate vaccine design Academic Article
- Immune Focusing and Enhanced Neutralization Induced by HIV-1 gp140 Chemical Cross-Linking Academic Article
- Immune tolerance negatively regulates B cells in knock-in mice expressing broadly neutralizing HIV antibody 4E10 Academic Article
- Immunization for HIV-1 broadly neutralizing antibodies in human Ig knockin mice Academic Article
- Immunization with wild-type or cd4-binding-defective hiv-1 env trimers reduces viremia equivalently following heterologous challenge with simian-human immunodeficiency virus Academic Article
- Immunogenic display of purified chemically cross-linked HIV-1 spikes Academic Article
- Immunogenicity evaluation strategy for a second-generation therapeutic, PEG-IFN-β-1a Academic Article
- Immunogenicity of HIV-1 envelope glycoprotein oligomers Academic Article
- Immunogenicity of stabilized HIV-1 envelope trimers with reduced exposure of non-neutralizing epitopes Academic Article
- Incomplete neutralization and deviation from sigmoidal neutralization curves for HIV broadly neutralizing monoclonal antibodies Academic Article
- Influence of novel cd4 binding-defective hiv-1 envelope glycoprotein immunogens on neutralizing antibody and t-cell responses in nonhuman primates Academic Article
- Influences on Trimerization and Aggregation of Soluble, Cleaved HIV-1 SOSIP Envelope Glycoprotein Academic Article
- Insights into the trimeric HIV-1 envelope glycoprotein structure Academic Article
- Isolation of potent SARS-CoV-2 neutralizing antibodies and protection from disease in a small animal model Academic Article
- Isolation of potent neutralizing antibodies from a survivor of the 2014 Ebola virus outbreak Academic Article
- Key gp120 glycans pose roadblocks to the rapid development of VRC01-class antibodies in an HIV-1-infected Chinese donor Academic Article
- LY2875358, a neutralizing and internalizing anti-MET bivalent antibody, inhibits HGF-dependent and HGF-independent MET activation and tumor growth Academic Article
- Ligand accessibility to the HIV-1 Env co-receptor binding site can occur prior to CD4 engagement and is independent of viral tier category Academic Article
- Limited or no protection by weakly or nonneutralizing antibodies against vaginal shiv challenge of macaques compared with a strongly neutralizing antibody Academic Article
- Live simian immunodeficiency virus vaccine correlate of protection: local antibody production and concentration on the path of virus entry Academic Article
- Mamu-B*17(+) rhesus macaques vaccinated with env, vif, and nef manifest early control of SIVmac239 replication Academic Article
- Manipulating the selection forces during affinity maturation to generate cross-reactive hiv antibodies Academic Article
- Maturation pathway from germline to broad HIV-1 neutralizer of a CD4-mimic antibody Academic Article
- Mechanism of human antibody-mediated neutralization of Marburg virus Academic Article
- Mechanism of neutralization by the broadly neutralizing HIV-1 monoclonal antibody VRC01 Academic Article
- Mechanisms of escape from the PGT128 family of anti-HIV broadly neutralizing antibodies Academic Article
- Mining the antibodyome for HIV-1-neutralizing antibodies with next-generation sequencing and phylogenetic pairing of heavy/light chains Academic Article
- Model building and refinement of a natively glycosylated HIV-1 Env protein by high-resolution cryoelectron microscopy Academic Article
- Modular synthesis of N-glycans and arrays for the hetero-ligand binding analysis of HIV antibodies Academic Article
- Multidonor analysis reveals structural elements, genetic determinants, and maturation pathway for HIV-1 neutralization by VRC01-class antibodies Academic Article
- Murine anti-vaccinia virus D8 antibodies target different epitopes and differ in their ability to block D8 binding to CS-E Academic Article
- Murine antibody responses to cleaved soluble HIV-1 envelope trimers are highly restricted in specificity Academic Article
- N332-directed broadly neutralizing antibodies use diverse modes of HIV-1 recognition: inferences from heavy-light chain complementation of function Academic Article
- Neutralization of tier-2 viruses and epitope profiling of plasma antibodies from human immunodeficiency virus type 1 infected donors from India Academic Article
- Neutralization potential of the plasma of HIV-1 infected Indian patients in the context of Anti-V3 antibody content and antiretroviral theraphy Academic Article
- Neutralization properties of simian immunodeficiency viruses infecting chimpanzees and gorillas Academic Article
- Neutralization resistance of hepatitis C virus can be overcome by recombinant human monoclonal antibodies Academic Article
- Neutralization takes precedence over IgG or IgA isotype-related functions in mucosal HIV-1 antibody-mediated protection Academic Article
- Neutralizing antibody-resistant hepatitis C virus cell-to-cell transmission Academic Article
- Neutralizing ebolavirus: Structural insights into the envelope glycoprotein and antibodies targeted against it Academic Article
- Neutralizing epitopes in the membrane-proximal external region of hiv-1 gp41 are influenced by the transmembrane domain and the plasma membrane Academic Article
- Optimal combinations of broadly neutralizing antibodies for prevention and treatment of HIV-1 clade C Academic Article
- Outer domain of HIV-1 gp120: antigenic optimization, structural malleability, and crystal structure with antibody VRC-PG04 Academic Article
- PGV04, an HIV-1 gp120 CD4 binding site antibody, is broad and potent in neutralization but does not induce conformational changes characteristic of CD4 Academic Article
- Pan-ebolavirus and pan-filovirus mouse monoclonal antibodies: protection against Ebola and Sudan viruses Academic Article
- Passive neutralizing antibody controls shiv viremia and enhances b cell responses in infant macaques Academic Article
- Passive transfer of modest titers of potent and broadly neutralizing anti-HIV monoclonal antibodies block SHIV infection in macaques Academic Article
- Pharmacokinetics and pharmacodynamics of peginterferon beta-1a in patients with relapsing-remitting multiple sclerosis in the randomized ADVANCE study Academic Article
- Platelet protein S directly inhibits procoagulant activity on platelets and microparticles Academic Article
- Potent antibody protection against an emerging alphavirus threat Academic Article
- Potent neutralizing antibodies from COVID-19 patients define multiple targets of vulnerability Academic Article
- Potent plasmablast-derived antibodies elicited by the national institutes of health dengue vaccine Academic Article
- Presenting native-like HIV-1 envelope trimers on ferritin nanoparticles improves their immunogenicity Academic Article
- Prevalence and predictors for homo- and heterosubtypic antibodies against influenza A virus. Academic Article
- Primate immune responses to HIV-1 Env formulated in the saponin-based adjuvant AbISCO-100 in the presence or absence of TLR9 co-stimulation Academic Article
- Prime-boost immunization of rabbits with HIV-1 gp120 elicits potent neutralization activity against a primary viral isolate Academic Article
- Priming HIV-1 broadly neutralizing antibody precursors in human Ig loci transgenic mice Academic Article
- Priming a broadly neutralizing antibody response to HIV-1 using a germline-targeting immunogen Academic Article
- Production and characterization of human anti-V3 monoclonal antibodies from the cells of HIV-1 infected Indian donors Academic Article
- Production of a human neutralizing monoclonal antibody and its crystal structure in complex with ectodomain 3 of the interleukin-13 receptor alpha 1 Academic Article
- Profiling human antibody responses by integrated single-cell analysis Academic Article
- Promiscuous glycan site recognition by antibodies to the high-mannose patch of gp120 broadens neutralization of HIV Academic Article
- Proof of principle for epitope-focused vaccine design Academic Article
- Protection against dengue disease by synthetic nucleic acid antibody prophylaxis/immunotherapy Academic Article
- Protection against high-dose highly pathogenic mucosal siv challenge at very low serum neutralizing titers of the antibody-like molecule cd4-igg2 Academic Article
- Protective efficacy of broadly neutralizing antibodies with incomplete neutralization activity against simian-human immunodeficiency virus in rhesus monkeys Academic Article
- Purification, modeling, and analysis of botulinum neurotoxin subtype a5 (bont/a5) from clostridium botulinum strain a661222 Academic Article
- Quantitative evaluation of protective antibody response induced by hepatitis E vaccine in humans Academic Article
- Rapid development of glycan-specific, broad, and potent anti-HIV-1 gp120 neutralizing antibodies in an R5 SIV/HIV chimeric virus infected macaque Academic Article
- Rational HIV immunogen design to target specific germline B cell receptors Academic Article
- Rational antibody-based HIV-1 vaccine design: current approaches and future directions Academic Article
- Rational design of envelope identifies broadly neutralizing human monoclonal antibodies to hiv-1 Academic Article
- Receptor mimicry by antibody F045-092 facilitates universal binding to the H3 subtype of influenza virus Academic Article
- Recombinant HIV envelope proteins fail to engage germline versions of anti-CD4bs bNAbs. Academic Article
- Recombinant HIV envelope trimer selects for quaternary-dependent antibodies targeting the trimer apex Academic Article
- Reducing V3 antigenicity and immunogenicity on soluble, native-like HIV-1 Env SOSIP trimers Academic Article
- Relationship between antibody 2f5 neutralization of hiv-1 and hydrophobicity of its heavy chain third complementarity-determining region Academic Article
- Reversion of somatic mutations of the respiratory syncytial virus-specific human monoclonal antibody Fab19 reveal a direct relationship between association rate and neutralizing potency Academic Article
- Rhesus macaque B-cell responses to an HIV-1 trimer vaccine revealed by unbiased longitudinal repertoire analysis Academic Article
- Robust neutralizing antibodies elicited by HIV-1 JRFL envelope glycoprotein trimers in nonhuman primates Academic Article
- SARS-CoV-2 and Three Related Coronaviruses Utilize Multipke ACE2 Orthologs and Are Potently Blocked by an Improved ACE2-Ig Academic Article
- Selection of unadapted, pathogenic SHIVs encoding newly transmitted HIV-1 envelope proteins Academic Article
- Selection pressure on hiv-1 envelope by broadly neutralizing antibodies to the conserved cd4-binding site Academic Article
- Sequence and structural convergence of broad and potent hiv antibodies that mimic cd4 binding Academic Article
- Simplifying the synthesis of SIgA: combination of dIgA and rhSC using affinity chromatography Academic Article
- SnapShot: broadly neutralizing antibodies Academic Article
- Specifically modified Env immunogens activate B-cell precursors of broadly neutralizing HIV-1 antibodies in transgenic mice Academic Article
- Stable 293 T and CHO cell lines expressing cleaved, stable HIV-1 envelope glycoprotein trimers for structural and vaccine studies Academic Article
- Stapled HIV-1 peptides recapitulate antigenic structures and engage broadly neutralizing antibodies Academic Article
- Strategies to determine assay format for the assessment of neutralizing antibody responses to biotherapeutics Academic Article
- Structural and immunologic correlates of chemically stabilized HIV-1 envelope glycoproteins Academic Article
- Structural basis for Marburg virus neutralization by a cross-reactive human antibody Academic Article
- Structural basis for broad and potent neutralization of HIV-1 by antibody VRC01 Academic Article
- Structural basis for diverse N-glycan recognition by HIV-1-neutralizing V1-V2-directed antibody PG16 Academic Article
- Structural basis for enhanced HIV-1 neutralization by a dimeric immunoglobulin G form of the glycan-recognizing antibody 2G12 Academic Article
- Structural basis of a shared antibody response to SARS-CoV-2 Academic Article
- Structural basis of hepatitis C virus neutralization by broadly neutralizing antibody HCV1 Academic Article
- Structural basis of immune evasion at the site of cd4 attachment on hiv-1 gp120 Academic Article
- Structural basis of preexisting immunity to the 2009 h1n1 pandemic influenza virus Academic Article
- Structural characterization of cleaved, soluble HIV-1 envelope glycoprotein trimers Academic Article
- Structural constraints determine the glycosylation of HIV-1 envelope trimers Academic Article
- Structural delineation of a quaternary, cleavage-dependent epitope at the gp41-gp120 interface on intact HIV-1 Env trimers Academic Article
- Structural evolution of glycan recognition by a family of potent HIV antibodies Academic Article
- Structural insights into key sites of vulnerability on hiv-1 env and influenza ha Academic Article
- Structural repertoire of HIV-1-neutralizing antibodies targeting the CD4 supersite in 14 donors Academic Article
- Structure and function of broadly reactive antibody PG16 reveal an H3 subdomain that mediates potent neutralization of HIV-1 Academic Article
- Structure and immunogenicity of a stabilized HIV-1 envelope trimer based on a group-M consensus sequence Academic Article
- Structure of 2G12 Fab2 in complex with soluble and fully glycosylated HIV-1 Env by negative-stain single-particle electron microscopy Academic Article
- Structure of HIV-1 gp120 V1/V2 domain with broadly neutralizing antibody PG9 Academic Article
- Structure of a classical broadly neutralizing stem antibody in complex with a pandemic H2 hemagglutinin Academic Article
- Structure of a classical broadly neutralizing stem antibody in complex with a pandemic h2 hemagglutinin Academic Article
- Structure of hepatitis C virus envelope glycoprotein E1 antigenic site 314-324 in complex with antibody IGH526 Academic Article
- Structure of hepatitis C virus envelope glycoprotein E2 antigenic site 412 to 423 in complex with antibody AP33 Academic Article
- Structure of the apo anti-influenza CH65 Fab Academic Article
- Structure-based vaccine design in hiv: Blind men and the elephant? Academic Article
- Structure-guided alterations of the gp41-directed hiv-1 broadly neutralizing antibody 2f5 reveal new properties regarding its neutralizing function Academic Article
- Supersite of immune vulnerability on the glycosylated face of HIV-1 envelope glycoprotein gp120 Academic Article
- Synthetic glycopeptides reveal the glycan specificity of HIV-neutralizing antibodies Academic Article
- Systematic comparison of respiratory syncytial virus-induced memory B cell responses in two anatomical compartments Academic Article
- Targeted isolation of antibodies directed against major sites of SIV Env vulnerability Academic Article
- Targeting HIV-1 gp41 in close proximity to the membrane using antibody and other molecules Academic Article
- Targeting the HIV-1 spike and coreceptor with bi- and trispecific antibodies for single-component broad inhibition of entry Academic Article
- The effects of somatic hypermutation on neutralization and binding in the PGT121 family of broadly neutralizing HIV antibodies Academic Article
- The first human epitope map of the alphaviral E1 and E2 proteins reveals a new E2 epitope with significant virus neutralizing activity Academic Article
- The impact of vaccination on the breadth and magnitude of the antibody response to influenza A viruses in HIV-infected individuals Academic Article
- Therapeutic efficacy of potent neutralizing HIV-1-specific monoclonal antibodies in SHIV-infected rhesus monkeys Academic Article
- Toward a more accurate view of human B-cell repertoire by next-generation sequencing, unbiased repertoire capture and single-molecule barcoding Academic Article
- Transplanting supersites of HIV-1 vulnerability Academic Article
- Trimerization of the HIV transmembrane domain in lipid bilayers modulates broadly neutralizing antibody binding Academic Article
- Two classes of broadly neutralizing antibodies within a single lineage directed to the high-mannose patch of HIV envelope Academic Article
- Two synthetic antibodies that recognize and neutralize distinct proteolytic forms of the ebola virus envelope glycoprotein Academic Article
- Universal protection against influenza infection by a multidomain antibody to influenza hemagglutinin Academic Article
- Unusual features of vaccinia virus extracellular virion form neutralization resistance revealed in human antibody responses to the smallpox vaccine Academic Article
- Using homology modeling to interrogate binding affinity in neutralization of ricin toxin by a family of single domain antibodies Academic Article
- V1/V2 neutralizing epitope is conserved in divergent non-M groups of HIV-1 Academic Article
- Vaccination with a synthetic peptide from the influenza virus hemagglutinin provides protection against distinct viral subtypes Academic Article
- Vaccine elicitation of high mannose-dependent neutralizing antibodies against the V3-glycan broadly neutralizing epitope in nonhuman primates Academic Article
- Vaccine-elicited primate antibodies use a distinct approach to the HIV-1 primary receptor binding site informing vaccine redesign Academic Article
- Vaccine-elicited tier 2 HIV-1 neutralizing antibodies bind to quaternary epitopes involving glycan-deficient patches proximal to the CD4 binding site Academic Article
- Variable loop glycan dependency of the broad and potent hiv-1-neutralizing antibodies pg9 and pg16 Academic Article
- Very few substitutions in a germ line antibody are required to initiate significant domain exchange Academic Article
- Well-ordered trimeric HIV-1 subtype B and C soluble spike mimetics generated by negative selection display native-like properties Academic Article
- bNAber: database of broadly neutralizing HIV antibodies Academic Article
- eCD4-Ig variants that more potently neutralize HIV-1 Academic Article